Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia

scientific article

Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.COPH.2011.01.003
P932PMC publication ID3075337
P698PubMed publication ID21317038
P5875ResearchGate publication ID49832176

P50authorKedra WallaceQ56256861
Babbette LaMarcaQ88459247
P2093author name stringJoey Granger
P2860cites workPrevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.Q54782424
Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of PreeclampsiaQ56981931
Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressureQ73567364
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertensionQ74126541
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculatureQ81423834
Pre-eclampsiaQ81446389
Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemiaQ82705098
What we have learned about preeclampsiaQ28196892
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptorQ33848380
Summary of the NHLBI Working Group on Research on Hypertension During PregnancyQ34182166
Recent Insights into the pathogenesis of pre-eclampsiaQ34682287
Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsiaQ35681821
Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant miceQ35701236
Role of the renin-angiotensin system in the pathogenesis of preeclampsiaQ36064478
Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsiaQ36380482
The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancyQ36407259
Clinical aspects of parvovirus B19 infectionQ36589340
Immunoregulation in normal pregnancy and pre-eclampsia: an overviewQ36684096
Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsiaQ37079628
The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsiaQ37088970
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant ratsQ37436219
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.Q37447371
Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide.Q43576536
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cellsQ44320558
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidaseQ44385661
Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activationQ45069619
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejectionQ45259438
Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsiaQ46332630
Preeclampsia is associated with lower percentages of regulatory T cells in maternal bloodQ47890265
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha.Q51359651
Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia.Q52940276
P433issue2
P921main subjectpre-eclampsiaQ61335
autoantibodyQ785022
P304page(s)175-179
P577publication date2011-04-01
P1433published inCurrent Opinion in PharmacologyQ3007702
P1476titleRole of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia
P478volume11

Reverse relations

cites work (P2860)
Q38126570A complicated role for the renin-angiotensin system during pregnancy: highlighting the importance of drug discovery
Q36052778AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction
Q27027039Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond
Q28534198Antibodies against AT1 receptors are associated with vascular endothelial and smooth muscle function impairment: protective effects of hydroxysafflor yellow A
Q26828588Antibodies in the pathogenesis of hypertension
Q36339273Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats
Q36115279Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system.
Q34025660Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome
Q36997267IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia
Q36409599Immune Mechanisms Linking Obesity and Preeclampsia
Q36241932International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].
Q55004295Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.
Q50937792Mechanism of agonistic angiotensin II type I receptor autoantibody-amplified contractile response to Ang II in the isolated rat thoracic aorta.
Q38845438Neurological Complications of Pregnancy
Q38017497Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome
Q39423454Pathophysiology and Current Clinical Management of Preeclampsia
Q35029497Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor
Q92071244Placental CD4+ T cells isolated from preeclamptic women cause preeclampsia-like symptoms in pregnant nude-athymic rats
Q37451544Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia
Q36422506Placental ischemia-induced increases in brain water content and cerebrovascular permeability: role of TNF-α
Q104137018Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction
Q34494348Presence of autoantibody against two placental proteins, peroxiredoxin 3 and peroxiredoxin 4, in sera of recurrent pregnancy loss patients
Q36537709RAS in Pregnancy and Preeclampsia and Eclampsia
Q39136791Recent Advances in Immunity and Hypertension
Q35707881Receptor-activating autoantibodies and disease: preeclampsia and beyond
Q88493279Regulators of G protein signaling in cardiovascular function during pregnancy
Q41653771Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.
Q47889401The Complement System and Preeclampsia
Q46238640The immunology of hypertension.
Q36979856The renin-angiotensin system in 2011: new avenues for translational research
Q33834419The role of inflammation in the pathology of preeclampsia
Q38116097Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis.
Q28391593Vascular Tissue Contractility Changes Following Late Gestational Exposure to Multi-Walled Carbon Nanotubes or their Dispersing Vehicle in Sprague Dawley Rats

Search more.